» Articles » PMID: 18209086

The Myeloid Differentiation Factor 88 (MyD88) is Required for CD4+ T Cell Effector Function in a Murine Model of Inflammatory Bowel Disease

Overview
Journal J Immunol
Date 2008 Jan 23
PMID 18209086
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal T cell responses to commensal bacteria are involved in the pathogenesis of inflammatory bowel disease. MyD88 is an essential signal transducer for TLRs in response to the microflora. We hypothesized that TLR signaling via MyD88 was important for effector T cell responses in the intestine. TLR expression on murine T cells was examined by flow cytometry. CD4(+)CD45Rb(high) T cells and/or CD4(+)CD45Rb(low)CD25(+) regulatory T cells were isolated and adoptively transferred to RAG1(-/-) mice. Colitis was assessed by changes in body weight and histology score. Cytokine production was assessed by ELISA. In vitro proliferation of T cells was assessed by [(3)H]thymidine assay. In vivo proliferation of T cells was assessed by BrdU and CFSE labeling. CD4(+)CD45Rb(high) T cells expressed TLR2, TLR4, TLR9, and TLR3, and TLR ligands could act as costimulatory molecules. MyD88(-/-) CD4(+) T cells showed decreased proliferation compared with WT CD4(+) T cells both in vivo and in vitro. CD4(+)CD45Rb(high) T cells from MyD88(-/-) mice did not induce wasting disease when transferred into RAG1(-/-) recipients. Lamina propria CD4(+) T cell expression of IL-2 and IL-17 and colonic expression of IL-6 and IL-23 were significantly lower in mice receiving MyD88(-/-) cells than mice receiving WT cells. In vitro, MyD88(-/-) T cells were blunted in their ability to secrete IL-17 but not IFN-gamma. Absence of MyD88 in CD4(+)CD45Rb(high) cells results in defective T cell function, especially Th17 differentiation. These results suggest a role for TLR signaling by T cells in the development of inflammatory bowel disease.

Citing Articles

Suppression of MyD88 disturbs gut microbiota and activates the NLR pathway and hence fails to ameliorate DSS-induced colitis.

Li J, Chen Y, Ye Z, Chen L, Xu J, Han J Precis Clin Med. 2024; 7(2):pbae013.

PMID: 38946731 PMC: 11212664. DOI: 10.1093/pcmedi/pbae013.


Immune response modulation in inflammatory bowel diseases by infection.

Feilstrecker Balani G, Dos Santos Cortez M, Picasky da Silveira Freitas J, de Melo F, Zarpelon-Schutz A, Teixeira K World J Gastroenterol. 2023; 29(30):4604-4615.

PMID: 37662864 PMC: 10472898. DOI: 10.3748/wjg.v29.i30.4604.


When the allergy alarm bells toll: The role of Toll-like receptors in allergic diseases and treatment.

Wenger M, Grosse-Kathoefer S, Kraiem A, Pelamatti E, Nunes N, Pointner L Front Mol Biosci. 2023; 10:1204025.

PMID: 37426425 PMC: 10325731. DOI: 10.3389/fmolb.2023.1204025.


Microbial sensing in the intestine.

Wan T, Wang Y, He K, Zhu S Protein Cell. 2023; 14(11):824-860.

PMID: 37191444 PMC: 10636641. DOI: 10.1093/procel/pwad028.


Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.

Abraham C, Abreu M, Turner J Gastroenterology. 2022; 162(6):1602-1616.e6.

PMID: 35149024 PMC: 9112237. DOI: 10.1053/j.gastro.2021.12.288.


References
1.
Ito H, Fathman C . CD45RBhigh CD4+ T cells from IFN-gamma knockout mice do not induce wasting disease. J Autoimmun. 1998; 10(5):455-9. DOI: 10.1016/s0896-8411(97)90152-9. View

2.
Suzuki N, Suzuki S, Millar D, Unno M, Hara H, Calzascia T . A critical role for the innate immune signaling molecule IRAK-4 in T cell activation. Science. 2006; 311(5769):1927-32. DOI: 10.1126/science.1124256. View

3.
Simpson S, Shah S, Comiskey M, de Jong Y, Wang B, Mizoguchi E . T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J Exp Med. 1998; 187(8):1225-34. PMC: 2212228. DOI: 10.1084/jem.187.8.1225. View

4.
Sutmuller R, Den Brok M, Kramer M, Bennink E, Toonen L, Kullberg B . Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest. 2006; 116(2):485-94. PMC: 1332026. DOI: 10.1172/JCI25439. View

5.
Komai-Koma M, Jones L, Ogg G, Xu D, Liew F . TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A. 2004; 101(9):3029-34. PMC: 365739. DOI: 10.1073/pnas.0400171101. View